|
Bayesian solution for study designs
|
|
0
|
3328
|
September 24, 2020
|
|
Factorial design - dropping factors and conditions
|
|
1
|
2624
|
September 1, 2020
|
|
Re-starting a Bayesian group sequential design trial after stopping it
|
|
4
|
3230
|
August 11, 2020
|
|
Stratification, block-randomization, etc
|
|
6
|
7486
|
August 4, 2020
|
|
Multiplicity in AIM-NIVO trial, uncontrolled by statistical discipline
|
|
0
|
2875
|
June 12, 2020
|
|
Seeking advice on Ethics and Efficiency of testing safety in a curative setting?
|
|
4
|
3654
|
May 31, 2020
|
|
When is censoring too high?
|
|
11
|
22176
|
May 28, 2020
|
|
Random vs. stratified sampling in estimating a varying treatment effect
|
|
0
|
2377
|
May 14, 2020
|
|
Self controlled case series
|
|
1
|
3186
|
May 6, 2020
|
|
COVID-19 Research Methods Resources
|
|
10
|
12542
|
May 4, 2020
|
|
Sample size calculation for intraclass correlation coefficient (ICC)
|
|
0
|
5146
|
May 1, 2020
|
|
Are hospital based retrospective cohort studies subject to Berkson's Bias?
|
|
1
|
2447
|
April 22, 2020
|
|
Illness Severity among Non-COVID patients
|
|
11
|
9039
|
April 19, 2020
|
|
Does Bayesian analysis render the 'primary endpoint' as irrelevant as multiplicity?
|
|
8
|
4982
|
April 10, 2020
|
|
Power calculations for cluster-RCT in hospital infection control (PPE for Covid19)
|
|
6
|
5976
|
April 1, 2020
|
|
Type I error in a specific design of 2-parallel group study
|
|
3
|
4083
|
March 11, 2020
|
|
Comparing continuous outcome in case-control-style design
|
|
2
|
3667
|
March 6, 2020
|
|
Advice on studying infections in persons who inject drugs
|
|
2
|
2470
|
February 25, 2020
|
|
Sample Size Calculation for Longitudinal Analysis of Haemoglobin Concentration
|
|
0
|
3068
|
February 2, 2020
|
|
Power and Sample Size Calculations in Pilot Studies
|
|
13
|
20450
|
December 3, 2019
|
|
Sample size calculations - when to consider interaction
|
|
3
|
6366
|
November 15, 2019
|
|
Outcome-based subgroups
|
|
7
|
6060
|
October 23, 2019
|
|
Sample size calculation for a marker to improve diagnosis
|
|
1
|
3845
|
October 21, 2019
|
|
Imbalance in pre-post studies
|
|
6
|
4645
|
October 2, 2019
|
|
How much patient variability is best for a clinical trial?
|
|
5
|
4356
|
September 22, 2019
|
|
Sample size estimation in a 3-treatment 3-period crossover study
|
|
2
|
3426
|
September 4, 2019
|
|
Observational study with no hypotheses
|
|
11
|
9104
|
August 29, 2019
|
|
Sample size calculation for correlation study
|
|
4
|
5772
|
August 2, 2019
|
|
Can a dataset be "overdispersed" if I'm not using a model with assumptions on normality?
|
|
2
|
2306
|
July 28, 2019
|
|
Bayesian Power: No Unobservables
|
|
6
|
8957
|
July 8, 2019
|